Spatial Biologics Private Limited is an R&D biotechnology company dedicated to accelerating preclinical molecular therapeutics and computational drug discovery. We specialize in GPU-accelerated molecular dynamics simulations, structure-based virtual screening, quantum chemical calculations (DFT), and multi-omics bioinformatic pipelines.
Simultaneously, our translational programs focus on overcoming antimicrobial resistance (AMR) through rationally designed antimicrobial peptides and functional biomaterial formulations. By bridging predictive computational biophysics with empirical biological characterization, we empower academic scholars, biotechnology enterprises, and institutional research labs to transition seamlessly from molecular hypotheses to validated preclinical leads.
Spatial Biologics operates across two complementary technological engines, unifying predictive computational modeling with empirical biological characterization.
A browser-accessible computational biology suite engineered to automate target preparation, molecular docking, molecular dynamics simulations, and predictive pharmacokinetics into reproducible research pipelines.
Preclinical R&D programs addressing antimicrobial resistance (AMR) and biofilm-forming pathogens through rationally designed antimicrobial peptides and functional biomaterial hydrogel formulations.